ABL Bio ranked among the top searched stocks for 10 days in the past month.

As of 2:30 PM on the 22nd, ABL Bio is trading at 36,500 KRW, up 5.04% from the previous day. This represents a 100.55% increase compared to May 27. ABL Bio is known as a specialized company developing bio-pharmaceuticals based on antibody therapeutics.

Today, foreigners have a tentative net purchase of 5,000 shares of ABL Bio, and institutions have a net purchase of 25,000 shares. Over the past five days, individual investors have net purchased 500,065 shares, while foreigners and institutions have net sold 349,139 shares and 70,472 shares, respectively.

On June 16, ABL Bio was a market topic with the headline "Benefiting from SK Biopharm’s IPO... Discussing technology transfers with 15 big pharma companies."



[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)
※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing